One study has reported that TGF-β is key to the radioresistance of tumor infiltrating T-cells [52], while others suggest TGF-β signaling suppresses the immune system and promotes cancer progression, pushing the need for the use of TGF-β pathway inhibitors [53]. This evidence concerns the gene TGFB1 and cancer.